Ironwood Financial, llc - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ironwood Financial, llc ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2020$533,000
-3.8%
36,490
-6.4%
0.20%
-28.4%
Q3 2020$554,000
-3.5%
38,9900.0%0.28%
-10.3%
Q2 2020$574,000
+256.5%
38,9900.0%0.31%
+181.8%
Q1 2020$161,000
+847.1%
38,990
+997.1%
0.11%
+1275.0%
Q4 2019$17,000
-22.7%
3,5540.0%0.01%
-27.3%
Q3 2019$22,000
-4.3%
3,5540.0%0.01%0.0%
Q2 2019$23,000
-8.0%
3,5540.0%0.01%
-15.4%
Q1 2019$25,000
+47.1%
3,5540.0%0.01%
+30.0%
Q4 2018$17,000
-41.4%
3,554
-11.2%
0.01%
-33.3%
Q3 2018$29,0000.0%4,004
-11.3%
0.02%
-11.8%
Q2 2018$29,000
+16.0%
4,5140.0%0.02%
-37.0%
Q1 2018$25,000
+66.7%
4,514
+27.2%
0.03%
+200.0%
Q4 2017$15,000
-55.9%
3,5500.0%0.01%
-57.1%
Q3 2017$34,000
-19.0%
3,5500.0%0.02%
-22.2%
Q2 2017$42,000
-8.7%
3,5500.0%0.03%
-10.0%
Q1 2017$46,000
+7.0%
3,5500.0%0.03%0.0%
Q4 2016$43,000
+2.4%
3,5500.0%0.03%0.0%
Q3 2016$42,000
+35.5%
3,5500.0%0.03%
+30.4%
Q2 2016$31,000
+55.0%
3,550
-7.3%
0.02%
+53.3%
Q1 2016$20,000
-33.3%
3,8300.0%0.02%0.0%
Q3 2015$30,000
+7.1%
3,830
+23.2%
0.02%
+15.4%
Q2 2015$28,000
-30.0%
3,1100.0%0.01%
-31.6%
Q1 2015$40,000
-21.6%
3,110
-17.3%
0.02%
-32.1%
Q4 2014$51,0003,7600.03%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders